These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 30995391)

  • 1. Combination of Double-Mediator System with Large-Scale Integration-Based Amperometric Devices for Detecting NAD(P)H:quinone Oxidoreductase 1 Activity of Cancer Cell Aggregates.
    Ino K; Onodera T; Fukuda MT; Nashimoto Y; Shiku H
    ACS Sens; 2019 Jun; 4(6):1619-1625. PubMed ID: 30995391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical monitoring of intracellular enzyme activity of single living mammalian cells by using a double-mediator system.
    Matsumae Y; Takahashi Y; Ino K; Shiku H; Matsue T
    Anal Chim Acta; 2014 Sep; 842():20-6. PubMed ID: 25127647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) and cytochrome P450 oxidoreductase (CYP450OR) differentially regulate menadione-mediated alterations in redox status, survival and metabolism in pancreatic β-cells.
    Gray JP; Karandrea S; Burgos DZ; Jaiswal AA; Heart EA
    Toxicol Lett; 2016 Nov; 262():1-11. PubMed ID: 27558805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells.
    Nishiyama T; Izawa T; Usami M; Ohnuma T; Ogura K; Hiratsuka A
    Biochem Biophys Res Commun; 2010 Apr; 394(3):459-63. PubMed ID: 20035715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coenzyme Q cytoprotective mechanisms for mitochondrial complex I cytopathies involves NAD(P)H: quinone oxidoreductase 1(NQO1).
    Chan TS; Teng S; Wilson JX; Galati G; Khan S; O'Brien PJ
    Free Radic Res; 2002 Apr; 36(4):421-7. PubMed ID: 12069106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation.
    Nishiyama T; Ohnuma T; Inoue Y; Kishi T; Ogura K; Hiratsuka A
    Biochem Biophys Res Commun; 2008 Jun; 371(2):247-50. PubMed ID: 18423374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A physiological threshold for protection against menadione toxicity by human NAD(P)H:quinone oxidoreductase (NQO1) in Chinese hamster ovary (CHO) cells.
    De Haan LH; Boerboom AM; Rietjens IM; van Capelle D; De Ruijter AJ; Jaiswal AK; Aarts JM
    Biochem Pharmacol; 2002 Dec; 64(11):1597-603. PubMed ID: 12429349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of pulmonary arterial endothelial cells on quinone redox status: effect of hyperoxia-induced NAD(P)H:quinone oxidoreductase 1.
    Merker MP; Audi SH; Bongard RD; Lindemer BJ; Krenz GS
    Am J Physiol Lung Cell Mol Physiol; 2006 Mar; 290(3):L607-19. PubMed ID: 16243901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrochemicolor Imaging Using an LSI-Based Device for Multiplexed Cell Assays.
    Kanno Y; Ino K; Abe H; Sakamoto C; Onodera T; Inoue KY; Suda A; Kunikata R; Matsudaira M; Shiku H; Matsue T
    Anal Chem; 2017 Dec; 89(23):12778-12786. PubMed ID: 29090905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of NAD(P)H:quinone oxidoreductase 1 (NQO1) and genomic gain of the NQO1 locus modulates breast cancer cell sensitivity to quinones.
    Glorieux C; Sandoval JM; Dejeans N; Ameye G; Poirel HA; Verrax J; Calderon PB
    Life Sci; 2016 Jan; 145():57-65. PubMed ID: 26687450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo.
    Dehn DL; Siegel D; Zafar KS; Reigan P; Swann E; Moody CJ; Ross D
    Mol Cancer Ther; 2006 Jul; 5(7):1702-9. PubMed ID: 16891456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrochemical Motion Tracking of Microorganisms Using a Large-Scale-Integration-Based Amperometric Device.
    Ino K; Kanno Y; Inoue KY; Suda A; Kunikata R; Matsudaira M; Shiku H; Matsue T
    Angew Chem Int Ed Engl; 2017 Jun; 56(24):6818-6822. PubMed ID: 28471045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger.
    Siegel D; Gustafson DL; Dehn DL; Han JY; Boonchoong P; Berliner LJ; Ross D
    Mol Pharmacol; 2004 May; 65(5):1238-47. PubMed ID: 15102952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of NAD(P)H:quinone oxidoreductase encoded by drgA gene in reduction of exogenous quinones in cyanobacterium Synechocystis sp. PCC 6803 cells.
    Elanskaya IV; Grivennikova VG; Groshev VV; Kuznetsova GV; Semina ME; Timofeev KN
    Biochemistry (Mosc); 2004 Feb; 69(2):137-42. PubMed ID: 15000679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
    Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
    Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Menadione-Mediated WST1 Reduction by Cultured Astrocytes Depends on NQO1 Activity and Cytosolic Glucose Metabolism.
    Ehrke E; Steinmeier J; Stapelfeldt K; Dringen R
    Neurochem Res; 2021 Jan; 46(1):88-99. PubMed ID: 31902045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
    Dehn DL; Winski SL; Ross D
    Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential utilization of NADPH as the endogenous electron donor for NAD(P)H:quinone oxidoreductase 1 (NQO1) in intact pulmonary arterial endothelial cells.
    Bongard RD; Lindemer BJ; Krenz GS; Merker MP
    Free Radic Biol Med; 2009 Jan; 46(1):25-32. PubMed ID: 18848878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo relevance of two critical levels for NAD(P)H:quinone oxidoreductase (NQO1)-mediated cellular protection against electrophile toxicity found in vitro.
    de Haan LH; Pot GK; Aarts JM; Rietjens IM; Alink GM
    Toxicol In Vitro; 2006 Aug; 20(5):594-600. PubMed ID: 16314070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.